Pharmaceutical Executive March 8, 2024
Miranda Schmalfuhs

In this Pharmaceutical Executive video interview, Daniel Ayala, Chief Security and Trust Officer, Dotmatics discusses how the data integrity landscape will evolve over the next five years and what extent bench scientists in the lab focused on data integrity.

Let’s forget about IT for just a minute, to what extent are the bench scientists in the lab focused on data integrity?

Researchers have always cared about the integrity and usefulness of their research. They’re very cognizant about getting a good entry, good and good entry that data in that they’ve collected in the lab and the good connection of the data from their instruments. But there’s a challenge in this world around the balance of security and usability and this...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Big Data, Biotechnology, Conferences / Podcast, Pharma, Pharma / Biotech, Technology, Trends
Is ‘Big Data’ the Cure-all for U.S. Healthcare?
The Rise Of Large Database Models
Moving from how data is moved to how it is managed
Data Management: The Key To Unlocking AI And BI Potential
Instant Insights: How To Harness The Power Of Real-Time Data

Share This Article